- Home
- TNON vs SONN Comparison
TNON vs SONN Comparison
Compare TNON & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- SONN
- Stock Information
- Founded
- TNON 2012
- SONN N/A
- Country
- TNON United States
- SONN United States
- Employees
- TNON N/A
- SONN N/A
- Industry
- TNON Medical Specialities
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- TNON Health Care
- SONN Health Care
- Exchange
- TNON Nasdaq
- SONN Nasdaq
- Market Cap
- TNON 2.2M
- SONN 2.5M
- IPO Year
- TNON 2022
- SONN N/A
- Fundamental
- Price
- TNON $1.85
- SONN $1.61
- Analyst Decision
- TNON Strong Buy
- SONN Strong Buy
- Analyst Count
- TNON 2
- SONN 2
- Target Price
- TNON $16.00
- SONN $148.00
- AVG Volume (30 Days)
- TNON 147.3K
- SONN 2.7M
- Earning Date
- TNON 11-13-2024
- SONN 12-17-2024
- Dividend Yield
- TNON N/A
- SONN N/A
- EPS Growth
- TNON N/A
- SONN N/A
- EPS
- TNON N/A
- SONN N/A
- Revenue
- TNON $3,315,000.00
- SONN $18,626.00
- Revenue This Year
- TNON $29.03
- SONN N/A
- Revenue Next Year
- TNON $100.29
- SONN N/A
- P/E Ratio
- TNON N/A
- SONN N/A
- Revenue Growth
- TNON 38.30
- SONN N/A
- 52 Week Low
- TNON $1.82
- SONN $1.57
- 52 Week High
- TNON $17.19
- SONN $18.72
- Technical
- Relative Strength Index (RSI)
- TNON 22.38
- SONN 24.41
- Support Level
- TNON $1.82
- SONN $1.73
- Resistance Level
- TNON $2.30
- SONN $1.94
- Average True Range (ATR)
- TNON 0.13
- SONN 0.48
- MACD
- TNON 0.01
- SONN 0.03
- Stochastic Oscillator
- TNON 5.88
- SONN 1.22
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.